Drug Profile
Anti-NB IgM antibody
Alternative Names: Anti-NB antibody; Anti-neuroblastoma IgM antibodyLatest Information Update: 13 Aug 2002
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neuroblastoma
Most Recent Events
- 11 Sep 1997 Preclinical development for Neuroblastoma in Germany (IV)